October 13, 2025
1 min read

Novo plant hit with FDA’s most serious inspection classification, portending possible delays for partners

The FDA has tagged Novo Nordisk’s newly acquired manufacturing facility in Indiana with an official action indicated label, which is the most severe of the three inspection classifications issued by the agency.

Leave a Reply

Your email address will not be published.

Previous Story

Syngene: Transforming Monoclonal Antibody Manufacturing for the Next Wave of Biologics

Next Story

BioNTech’s African mRNA vaccine production push gets EU funding boost

Previous Story

Syngene: Transforming Monoclonal Antibody Manufacturing for the Next Wave of Biologics

Next Story

BioNTech’s African mRNA vaccine production push gets EU funding boost

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop